STOCK TITAN

Zai Lab to Host Webcast Presentation to Discuss Data from Early Clinical Program Evaluating Its Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) has announced an upcoming investor webcast to discuss data from a Phase 1 clinical trial of ZL-1310, their investigational DLL3-targeted antibody-drug conjugate (ADC) for patients with advanced stage small cell lung cancer (SCLC). The live conference call and webcast is scheduled for October 24, 2024, at 8:30 a.m. ET (8:30 p.m. HKT), following a plenary oral presentation at the EORTC-NCI-AACR Symposium (ENA) 2024.

Interested parties can access the live webcast through Zai Lab's website at http://ir.zailaboratory.com. Participants must register in advance using the provided link: https://register.vevent.com/register/BI6f8ba8dc42d04cd3afd7095cf7c83d40. Upon registration, dial-in details will be sent via confirmation email. A replay of the webcast will be available on the company's website shortly after the call.

Positive
  • None.
Negative
  • None.

Company to host conference call and webcast on October 24, 2024, at 8:30 a.m. ET (8:30 p.m. HKT), following plenary oral presentation of data at the EORTC-NCI-AACR Symposium (ENA) 2024

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will hold an investor webcast to discuss data from a Phase 1 clinical trial of ZL-1310, the Company’s investigational DLL3-targeted antibody-drug conjugate (ADC), in patients with advanced stage small cell lung cancer (SCLC). The live conference call and webcast will take place on Thursday, October 24, 2024, at 8:30 a.m. ET (8:30 p.m. HKT).

Conference Call and Webcast Information

Listeners may access the live webcast by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call.

Details are as follows:

Registration Link: https://register.vevent.com/register/BI6f8ba8dc42d04cd3afd7095cf7c83d40

All participants must use the link provided above to complete the online registration process in advance of the conference call. Dial-in details will be in the confirmation email which the participant will receive upon registering.

A replay will be available shortly after the call and can be accessed by visiting the Company's website.

About Zai Lab

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide.

For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

Investor Relations:

Christine Chiou / Lina Zhang

+1 (917) 886-6929 / +86 136 8257 6943

christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com

Media:

Shaun Maccoun/ Xiaoyu Chen

+1 (857) 270-8854 / +86 185 0015 5011

shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.com

Source: Zai Lab Limited

FAQ

When is Zai Lab hosting the webcast to discuss ZL-1310 clinical data?

Zai Lab is hosting the webcast on October 24, 2024, at 8:30 a.m. ET (8:30 p.m. HKT) to discuss data from the Phase 1 clinical trial of ZL-1310.

What is ZL-1310 and what is it being developed for?

ZL-1310 is an investigational DLL3-targeted antibody-drug conjugate (ADC) being developed by Zai Lab for patients with advanced stage small cell lung cancer (SCLC).

How can investors access the Zai Lab webcast on October 24, 2024?

Investors can access the live webcast by visiting Zai Lab's website at http://ir.zailaboratory.com. They must also register in advance using the provided link to receive dial-in details.

What event precedes Zai Lab's webcast presentation on ZL-1310?

The webcast follows a plenary oral presentation of data at the EORTC-NCI-AACR Symposium (ENA) 2024.

Will there be a replay available of Zai Lab's ZL-1310 data presentation?

Yes, a replay of the webcast will be available shortly after the call on Zai Lab's website.

Zai Lab Limited American Depositary Shares

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Stock Data

2.57B
97.47M
1.99%
44.88%
4.68%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SHANGHAI